2023 Policy Forecasts

Welcome to Capstone’s annual forecast of unappreciated policy and regulatory themes companies, investors, and, industries should expect to play out over the course of the year.

Connect with us

Our Latest Insights

Untangling the Outlook for NIH Funding and Its Impact on Pharma

Untangling the Outlook for NIH Funding and Its Impact on Pharma

Capstone believes funding for the National Institutes of Health (NIH) will remain stable for the next 3-5 years, and investors should look past headline appropriations to specific therapeutic area (TA) to assess regulatory risk. Congress continues to insulate funding...

The IRS Ruling Targeting Tax-Aware ETF Strategies

The IRS Ruling Targeting Tax-Aware ETF Strategies

We believe the Internal Revenue Service’s (IRS) September 28th ruling taxing certain Section 351 transactions signals further restrictions on other aggressive tax-aware strategies over the next two years, which is a negative for exchange-traded fund (ETF) sponsors and...